search

Active clinical trials for "Hepatitis"

Results 3131-3140 of 3482

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis...

Hepatitis BChronic

This retrospective study will evaluate the association of biomarkers and the treatment response of patients with chronic hepatitis B, who have completed therapy with Pegasys (peginterferon alfa-2a) ± lamivudine. For the analysis stored serum samples obtained from patients will be used; no actual patients are involved.

Completed3 enrollment criteria

A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C

Hepatitis CChronic

This retrospective, observational study will assess the real world treatment out comes in the management of patients with chronic hepatitis C. No prospective ass essment or procedure with patients during this study will be conducted. Data wil l be collected from patient medical records of the year 2000-2011.

Completed5 enrollment criteria

Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B

Chronic Hepatitis B

The aim of our study is to evaluate liver fibrosis using biochemical markers, FibroScan, and radiology methods in patients with chronic hepatitis B in mainland China.

Completed4 enrollment criteria

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in...

Hepatitis CChronic

Primary objective: • Develop and validate a tool towards patients with chronic hepatitis C genotype 1 and 4 to allow optimize treatment.

Completed10 enrollment criteria

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in...

Chronic Hepatitis BHepatic Fibrosis1 more

Hepatic steatosis and insulin resistance are associated with severity of fibrosis in non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C. However, clinical significance of steatosis and insulin resistance on fibrosis in chronic hepatitis B (CHB) is not well established. The aim was to investigate the relationship between insulin resistance, hepatic steatosis, and fibrosis in patients with CHB.

Completed3 enrollment criteria

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Hepatitis B VirusAllograft1 more

The purpose of this study is to evaluate the risk of hepatitis B reactivation in patients undergoing allografting.

Completed1 enrollment criteria

Hepatitis C Virus (HCV) Treatment Completion or Withdrawal

Hepatitis C

Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.

Completed2 enrollment criteria

Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study...

Hepatitis CChronic1 more

Participants will receive PegIntron injection pen (Peginterferon alfa-2b) and Rebetol (Ribavirin) combination therapy as their usual medical treatment. The current study aims to evaluate whether the previously introduced, and now widely accepted and implemented educational program, which represents additional efforts in everyday practice to increase patient compliance, will succeed in achieving adherence rate in treated participants similar to the extent demonstrated by clinical trials.

Completed2 enrollment criteria

Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With...

Hepatitis CChronic1 more

In February 2002, a French Consensus Conference on the management of patients with chronic hepatitis C in France was organized. The jury issued several recommendations on pegylated alpha interferon/ribavirin treatment strategy. Three years after these recommendations, it is of interest to understand the evolution of hepatitis C management in France in real clinical practice. This observational study will permit the identification of patients who are treated and will provide information on the use of PegIntron/ Ribavirin.

Completed2 enrollment criteria

Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)

Hepatitis CChronic

This is an observational, multicenter, nationwide study where information will be collected on the follow-up of participants with chronic hepatitis C virus (HCV) who have a viral response at the end of treatment with pegylated interferon alfa-2b (PEG IFN alfa-2b) plus ribavirin (RBV) administered according to the directions on the products' labeling. No administration of treatment is planned as a result of study enrollment.

Completed8 enrollment criteria
1...313314315...349

Need Help? Contact our team!


We'll reach out to this number within 24 hrs